Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 5,668 $ 4,072
Premium and trade receivables 3,648 3,413
Short-term investments 507 531
Other current assets 1,153 687
Total current assets 10,976 8,703
Long-term investments 5,535 5,312
Restricted deposits 140 135
Property, software and equipment, net 1,250 1,104
Goodwill 5,295 4,749
Intangible assets, net 1,519 1,398
Other long-term assets 455 454
Total assets 25,170 21,855
Current liabilities:    
Medical claims liability 4,771 4,286
Accounts payable and accrued expenses 4,962 4,165
Return of premium payable 515 549
Unearned revenue 638 328
Current portion of long-term debt 4 4
Total current liabilities 10,890 9,332
Long-term debt 5,172 4,695
Other long-term liabilities 1,520 952
Total liabilities 17,582 14,979
Commitments and contingencies
Redeemable noncontrolling interests 8 12
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2018 and December 31, 2017 0 0
Common stock, $0.001 par value; authorized 400,000 shares; 180,643 issued and 176,795 outstanding at March 31, 2018, and 180,379 issued and 173,437 outstanding at December 31, 2017 0 0
Additional paid-in capital 4,592 4,349
Accumulated other comprehensive (loss) (54) (3)
Retained earnings 3,104 2,748
Treasury stock, at cost (3,848 and 6,942 shares, respectively) (139) (244)
Total Centene stockholders’ equity 7,503 6,850
Noncontrolling interest 77 14
Total stockholders’ equity 7,580 6,864
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 25,170 $ 21,855